MA26582A1 - Derives de thiazolidinedione nouveau, procede pour sa preparation et composition pharmaceutique le contenant - Google Patents

Derives de thiazolidinedione nouveau, procede pour sa preparation et composition pharmaceutique le contenant

Info

Publication number
MA26582A1
MA26582A1 MA25392A MA25392A MA26582A1 MA 26582 A1 MA26582 A1 MA 26582A1 MA 25392 A MA25392 A MA 25392A MA 25392 A MA25392 A MA 25392A MA 26582 A1 MA26582 A1 MA 26582A1
Authority
MA
Morocco
Prior art keywords
same
preparing
pharmaceutical composition
composition containing
thiazolidinedione derivatives
Prior art date
Application number
MA25392A
Other languages
English (en)
Inventor
Paul David James Blackler
Mr David C Lee
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA26582A1 publication Critical patent/MA26582A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
MA25392A 1997-12-16 1998-12-14 Derives de thiazolidinedione nouveau, procede pour sa preparation et composition pharmaceutique le contenant MA26582A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9726568.0A GB9726568D0 (en) 1997-12-16 1997-12-16 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
MA26582A1 true MA26582A1 (fr) 2004-12-20

Family

ID=10823694

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25392A MA26582A1 (fr) 1997-12-16 1998-12-14 Derives de thiazolidinedione nouveau, procede pour sa preparation et composition pharmaceutique le contenant

Country Status (37)

Country Link
US (2) US7045633B2 (fr)
EP (1) EP1045847A1 (fr)
JP (1) JP2002508372A (fr)
KR (1) KR100549143B1 (fr)
CN (3) CN1281454A (fr)
AP (1) AP1441A (fr)
AR (2) AR017430A1 (fr)
AU (1) AU2272399A (fr)
BG (1) BG64905B1 (fr)
BR (1) BR9813604A (fr)
CA (1) CA2314965A1 (fr)
CO (1) CO4990927A1 (fr)
CZ (1) CZ299970B6 (fr)
DZ (1) DZ2680A1 (fr)
EA (1) EA002355B1 (fr)
EG (2) EG21417A (fr)
GB (1) GB9726568D0 (fr)
HR (1) HRP20000405A2 (fr)
HU (1) HUP0100500A3 (fr)
ID (1) ID24744A (fr)
IL (1) IL136381A (fr)
IN (1) IN190821B (fr)
MA (1) MA26582A1 (fr)
MY (1) MY135770A (fr)
NO (1) NO317253B1 (fr)
NZ (1) NZ504704A (fr)
OA (1) OA11634A (fr)
PE (1) PE20000057A1 (fr)
PL (1) PL341147A1 (fr)
RS (1) RS50079B (fr)
SK (1) SK286197B6 (fr)
TR (2) TR200001798T2 (fr)
TW (1) TW467913B (fr)
UA (1) UA63980C2 (fr)
UY (2) UY25305A1 (fr)
WO (1) WO1999031094A1 (fr)
ZA (1) ZA9811505B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
SK286423B6 (sk) * 1999-04-23 2008-09-05 Smithkline Beecham Plc Polymorfná forma soli 5-[4-[2-(N-metyl-N-2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu s kyselinou maleínovou, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie
KR100744361B1 (ko) * 1999-04-23 2007-07-30 스미스클라인비이참피이엘시이 티아졸리딘디온 유도체 및 항당뇨병제로서 그의 용도
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021978D0 (en) * 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
AU2002350965A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
AU2002352391A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc A 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione (i) 10-camphorsulphonic acid salt and use against diabetes mellitus
GB0130511D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
WO2003053962A1 (fr) * 2001-12-20 2003-07-03 Smithkline Beecham Plc Sel d'acide malique 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy) benzyl) thiazolidine-2, 4-dione et son utilisation contre le diabete sucre
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP2184055A1 (fr) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Procédé de préparation de formes galéniques solides de maléate de rosiglitazone

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
EP0842925A1 (fr) * 1987-09-04 1998-05-20 Beecham Group Plc Thiazolidinédiones substituées
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
GB9124513D0 (en) 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
EP0656900A4 (fr) 1992-08-28 1995-09-06 Merck & Co Inc Agents antibacteriens au carbapeneme-heteroaryphenyle-2-cationique.
US5741803A (en) 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
GB9218830D0 (en) 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
TW245716B (fr) * 1992-12-28 1995-04-21 Takeda Pharm Industry Co
DE4404198A1 (de) 1994-02-10 1995-08-17 Henkel Kgaa 2-Fluor-6-nitroaniline
GB9726563D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726566D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) * 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
CZ432299A3 (cs) * 1998-06-02 2000-08-16 Smithkline Beecham Plc Kompozice obsahující 5-[4-[2-(N-methyl-N-(2- pyridyI)amino)ethoxy]benzyl]thiazolidin-2,4-dion
UA67844C2 (uk) 1999-04-23 2004-07-15 Смітклайн Бічам Плс Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти
SK286423B6 (sk) 1999-04-23 2008-09-05 Smithkline Beecham Plc Polymorfná forma soli 5-[4-[2-(N-metyl-N-2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu s kyselinou maleínovou, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie
KR100744361B1 (ko) 1999-04-23 2007-07-30 스미스클라인비이참피이엘시이 티아졸리딘디온 유도체 및 항당뇨병제로서 그의 용도

Also Published As

Publication number Publication date
TW467913B (en) 2001-12-11
CZ299970B6 (cs) 2009-01-07
HUP0100500A2 (hu) 2002-05-29
PL341147A1 (en) 2001-03-26
IN190821B (fr) 2003-08-23
WO1999031094A1 (fr) 1999-06-24
YU36200A (sh) 2003-12-31
DZ2680A1 (fr) 2005-02-20
TR199802626A2 (xx) 1999-10-21
CN1281454A (zh) 2001-01-24
TR199802626A3 (tr) 1999-10-21
PE20000057A1 (es) 2000-03-09
UA63980C2 (en) 2004-02-16
OA11634A (en) 2004-11-22
NZ504704A (en) 2003-03-28
AP2000001830A0 (en) 2000-06-30
BG104595A (en) 2001-02-28
CN101412714A (zh) 2009-04-22
EG23694A (en) 2007-05-15
US20040097553A1 (en) 2004-05-20
KR100549143B1 (ko) 2006-02-03
IL136381A (en) 2003-09-17
US7045633B2 (en) 2006-05-16
JP2002508372A (ja) 2002-03-19
BR9813604A (pt) 2000-10-10
CZ20002205A3 (cs) 2000-11-15
US20060189659A1 (en) 2006-08-24
ID24744A (id) 2000-08-03
EP1045847A1 (fr) 2000-10-25
EA002355B1 (ru) 2002-04-25
CN101412713A (zh) 2009-04-22
HRP20000405A2 (en) 2000-12-31
SK286197B6 (sk) 2008-05-06
NO20003068D0 (no) 2000-06-15
EA200000655A1 (ru) 2000-12-25
AU2272399A (en) 1999-07-05
TR200001798T2 (tr) 2000-11-21
CO4990927A1 (es) 2000-12-26
AR017213A1 (es) 2001-08-22
GB9726568D0 (en) 1998-02-11
AP1441A (en) 2005-07-30
UY25310A1 (es) 1999-07-19
UY25305A1 (es) 2000-12-29
EG21417A (en) 2001-10-31
IL136381A0 (en) 2001-06-14
NO317253B1 (no) 2004-09-27
MY135770A (en) 2008-06-30
HUP0100500A3 (en) 2002-08-28
SK9102000A3 (en) 2001-01-18
ZA9811505B (en) 2000-11-06
KR20010033142A (ko) 2001-04-25
AR017430A1 (es) 2001-09-05
BG64905B1 (bg) 2006-08-31
RS50079B (sr) 2009-01-22
NO20003068L (no) 2000-06-15
CA2314965A1 (fr) 1999-06-24

Similar Documents

Publication Publication Date Title
MA26472A1 (fr) Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26415A1 (fr) Composes heterocycliques, procede pour la preparation et compositions pharmaceutiques les contenant
MA26479A1 (fr) Derives de nicotinamide, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26432A1 (fr) Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26424A1 (fr) Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26438A1 (fr) Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26468A1 (fr) Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26433A1 (fr) Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2780057B1 (fr) Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26687A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26559A1 (fr) Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
FR2740136B1 (fr) Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
MA26630A1 (fr) 4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26526A1 (fr) Derives d'indole inhibiteurs de cyclo-oxygenase, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26680A1 (fr) Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2729951B1 (fr) Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant
FR2780728B1 (fr) Sel de paroxetine nouveau, procede pour sa preparation et compositions pharmaceutiques le contenant
MA26499A1 (fr) Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant .
MA26558A1 (fr) Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26505A1 (fr) Derives de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26519A1 (fr) Derives d'azetidinylpropylpiperidine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26582A1 (fr) Derives de thiazolidinedione nouveau, procede pour sa preparation et composition pharmaceutique le contenant
MA26501A1 (fr) Derives de quinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26552A1 (fr) Derives d'isoquinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26609A1 (fr) Derives de retiferol, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation